IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?

Autor: Bispo Júnior, Rosalvo Zósimo, Camargo, Olavo Pires de
Zdroj: In Revista Brasileira de Ortopedia (English Edition) July-August 2011 46(4):420-423
Databáze: ScienceDirect